FDA.reportPublic FDA data

Celonia CM

Manufacturer
MEDIPOST Co.,Ltd. | Kolmar Korea Co., Ltd.
Effective date
2016-03-11
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:27:57

Label at a glance#

ProductCelonia CM
Active ingredientNIACINAMIDE
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: NIACINAMIDE 2.8%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: WATER, HUMAN CORD BLOOD CELL CONDITIO NED MEDIA, GLYCERIN, METHYLPROPANEDIOL, 1,2-HEXANEDIOL, BETAINE, BUTYLENE GLYCOL, PANTHENOL, PROPANEDIOL, PIPER METHYSTICUM LEAF/ROOT/STEM EXTRACT, ARCTIUM LAPPA ROOT EXTRACT, PHELLINUS LINTEUS EXTRACT, CHOLESTEROL, SOLUBLE COLLAGEN, BIFIDA FERMENT LYSATE, PORTULACA OLERACEA EXTRACT, PUERARIA THUNBERGIANA ROOT EXTRACT, CNIDIUM OFFICINALE ROOT EXTRACT, GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT, PAEONIA LACTIFLORA ROOT EXTRACT, ETHYLHEXYLGLYCERIN, HYDROGENATED LECITHIN, SODIUM CITRATE, PHENOXYETHANOL, ALOE BARBADENSIS LEAF JUICE, CELLULOSE GUM, ADENOSINE, CITRIC ACID, SODIUM HYALURONATE, DISODIUM EDTA, CERAMIDE NP, TROMETHAMINE, XANTHAN GUM, ARGANIA SPINOSA KERNEL OIL, ACETIC ACID, LACTIC ACID, TOCOPHERYL LINOLEATE, POTASSIUM SORBATE

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Protectant

WARNINGS

WARNINGS SECTION

Warnings: 1. If following symptoms occur, stop use and consult a doctor: red spots, swelling, itcihng, irritation, or symtoms on applied skin under direct sunlight. 2. Do not use on scarred skin, or if you have dermatitis or eczema 3. Keep the cap close on its product 4. Keep away from direct sunlight or heat. 5. Keep out of reach of children

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indications & usage: Apply smoothly on the entire face in the morning and night.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage & administration: Take an adequate amount of this product.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70506-120-012023-06-30C16284748780-19d75b9d0-3226-f424-e053-dadaa90a57ce76647f29-2c66-4eb6-ae55-2d060b536979
70506-120-012020-01-31C16284748780-19d75b9d0-3226-f424-e053-dadaa90a57ce76647f29-2c66-4eb6-ae55-2d060b536979

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70506-12070506-120-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
NIACINAMIDE25X51I8RD4ACTIB
WATER059QF0KO0RIACT
GLYCERINPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bcc7e84d-b706-4579-8587-f22a1f07e00676647f29-2c66-4eb6-ae55-2d060b5369792023-06-30WarningsExact identifier
spl set id: 76647f29-2c66-4eb6-ae55-2d060b536979

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.